/DaVita%20Inc%20logo%20on%20building-by%20JHVEPhoto%20via%20iStock.jpg)
DaVita Inc. (DVA), headquartered in Denver, Colorado, provides kidney dialysis services to patients with chronic kidney failure. Valued at $9 billion by market cap, the company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. The kidney care giant is expected to announce its fiscal third-quarter earnings for 2025 after the market closes on Wednesday, Oct. 29.
Ahead of the event, analysts expect DVA to report a profit of $3.29 per share on a diluted basis, up 27% from $2.59 per share in the year-ago quarter. The company beat the consensus estimates in three of the last four quarters while missing the forecast on another occasion.